Copyright Reports & Markets. All rights reserved.

Global Rheumatic Disorders Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Rheumatic Disorders Drug Market Overview

    • 1.1 Product Overview and Scope of Rheumatic Disorders Drug
    • 1.2 Classification of Rheumatic Disorders Drug by Types
      • 1.2.1 Global Rheumatic Disorders Drug Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Rheumatic Disorders Drug Revenue Market Share by Types in 2018
      • 1.2.3 Acting on Tumor Necrosis Factor-Alpha
      • 1.2.4 Acting on Interleukins and Interleukin Receptors
      • 1.2.5 Acting on Protein Kinases
      • 1.2.6 Acting on Cell Surface Antigens
      • 1.2.7 Acting on Hormones and Hormone Receptors
      • 1.2.8 Others
    • 1.3 Global Rheumatic Disorders Drug Market by Application
      • 1.3.1 Global Rheumatic Disorders Drug Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Rheumatoid Arthritis
      • 1.3.3 Osteoarthritis
      • 1.3.4 Osteoporosis
      • 1.3.5 Systemic Lupus Erythematosus
      • 1.3.6 Psoriatic Arthritis
      • 1.3.7 Others
    • 1.4 Global Rheumatic Disorders Drug Market by Regions
      • 1.4.1 Global Rheumatic Disorders Drug Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Rheumatic Disorders Drug Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Rheumatic Disorders Drug Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rheumatic Disorders Drug Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Rheumatic Disorders Drug Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rheumatic Disorders Drug Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Rheumatic Disorders Drug (2014-2024)

    2 Company Profiles

    • 2.1 AbbVie
      • 2.1.1 Business Overview
      • 2.1.2 Rheumatic Disorders Drug Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 AbbVie Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Amgen
      • 2.2.1 Business Overview
      • 2.2.2 Rheumatic Disorders Drug Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Amgen Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Johnson & Johnson
      • 2.3.1 Business Overview
      • 2.3.2 Rheumatic Disorders Drug Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Johnson & Johnson Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Novartis
      • 2.4.1 Business Overview
      • 2.4.2 Rheumatic Disorders Drug Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Novartis Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Pfizer
      • 2.5.1 Business Overview
      • 2.5.2 Rheumatic Disorders Drug Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Pfizer Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Roche
      • 2.6.1 Business Overview
      • 2.6.2 Rheumatic Disorders Drug Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Roche Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Eli Lilly
      • 2.7.1 Business Overview
      • 2.7.2 Rheumatic Disorders Drug Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Eli Lilly Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Bristol-Myers Squibb
      • 2.8.1 Business Overview
      • 2.8.2 Rheumatic Disorders Drug Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Bristol-Myers Squibb Rheumatic Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Rheumatic Disorders Drug Market Competition, by Players

    • 3.1 Global Rheumatic Disorders Drug Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Rheumatic Disorders Drug Players Market Share
      • 3.2.2 Top 10 Rheumatic Disorders Drug Players Market Share
    • 3.3 Market Competition Trend

    4 Global Rheumatic Disorders Drug Market Size by Regions

    • 4.1 Global Rheumatic Disorders Drug Revenue and Market Share by Regions
    • 4.2 North America Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 4.5 South America Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)

    5 North America Rheumatic Disorders Drug Revenue by Countries

    • 5.1 North America Rheumatic Disorders Drug Revenue by Countries (2014-2019)
    • 5.2 USA Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)

    6 Europe Rheumatic Disorders Drug Revenue by Countries

    • 6.1 Europe Rheumatic Disorders Drug Revenue by Countries (2014-2019)
    • 6.2 Germany Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 6.3 UK Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 6.4 France Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Rheumatic Disorders Drug Revenue by Countries

    • 7.1 Asia-Pacific Rheumatic Disorders Drug Revenue by Countries (2014-2019)
    • 7.2 China Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 7.5 India Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)

    8 South America Rheumatic Disorders Drug Revenue by Countries

    • 8.1 South America Rheumatic Disorders Drug Revenue by Countries (2014-2019)
    • 8.2 Brazil Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Rheumatic Disorders Drug by Countries

    • 9.1 Middle East and Africa Rheumatic Disorders Drug Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Rheumatic Disorders Drug Revenue and Growth Rate (2014-2019)

    10 Global Rheumatic Disorders Drug Market Segment by Type

    • 10.1 Global Rheumatic Disorders Drug Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Rheumatic Disorders Drug Market Forecast by Type (2019-2024)
    • 10.3 Acting on Tumor Necrosis Factor-Alpha Revenue Growth Rate (2014-2024)
    • 10.4 Acting on Interleukins and Interleukin Receptors Revenue Growth Rate (2014-2024)
    • 10.5 Acting on Protein Kinases Revenue Growth Rate (2014-2024)
    • 10.6 Acting on Cell Surface Antigens Revenue Growth Rate (2014-2024)
    • 10.7 Acting on Hormones and Hormone Receptors Revenue Growth Rate (2014-2024)
    • 10.8 Others Revenue Growth Rate (2014-2024)

    11 Global Rheumatic Disorders Drug Market Segment by Application

    • 11.1 Global Rheumatic Disorders Drug Revenue Market Share by Application (2014-2019)
    • 11.2 Rheumatic Disorders Drug Market Forecast by Application (2019-2024)
    • 11.3 Rheumatoid Arthritis Revenue Growth (2014-2019)
    • 11.4 Osteoarthritis Revenue Growth (2014-2019)
    • 11.5 Osteoporosis Revenue Growth (2014-2019)
    • 11.6 Systemic Lupus Erythematosus Revenue Growth (2014-2019)
    • 11.7 Psoriatic Arthritis Revenue Growth (2014-2019)
    • 11.8 Others Revenue Growth (2014-2019)

    12 Global Rheumatic Disorders Drug Market Size Forecast (2019-2024)

    • 12.1 Global Rheumatic Disorders Drug Market Size Forecast (2019-2024)
    • 12.2 Global Rheumatic Disorders Drug Market Forecast by Regions (2019-2024)
    • 12.3 North America Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
    • 12.4 Europe Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
    • 12.6 South America Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Rheumatic Disorders Drug Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Treatment of drugs for regulating rheumatic diseases

      Scope of the Report:
      Rheumatic diseases are a series of diseases characterized by chronic pain. Some of the most common diseases are osteoarthritis (OA) and rheumatoid arthritis (RA), and most rheumatic diseases use basically universal pain control drugs. Treatment is ongoing and there are no treatments for any of the key indications, so there is a need to develop better disease modulating drugs.
      The global Rheumatic Disorders Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rheumatic Disorders Drug.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Rheumatic Disorders Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rheumatic Disorders Drug market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      AbbVie
      Amgen
      Johnson & Johnson
      Novartis
      Pfizer
      Roche
      Eli Lilly
      Bristol-Myers Squibb

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Acting on Tumor Necrosis Factor-Alpha
      Acting on Interleukins and Interleukin Receptors
      Acting on Protein Kinases
      Acting on Cell Surface Antigens
      Acting on Hormones and Hormone Receptors
      Others

      Market Segment by Applications, can be divided into
      Rheumatoid Arthritis
      Osteoarthritis
      Osteoporosis
      Systemic Lupus Erythematosus
      Psoriatic Arthritis
      Others
      Buy now